Patent application number | Description | Published |
20100069619 | STILBENE DERIVATIVES FOR ADP-RIBOSYL CYCLASE INHIBITORS - The present disclosure relates to bisphenyl compounds that are useful for inhibit the ADP-ribosyl cyclase (ADPR-cyclase). More particularly, the disclosed compounds can be used for treatment and prevention of hypertension, hypertensive cardiac hypertrophy, diabetes, and diabetic nephropathy, in which pathogenesis ADPR-cyclase is involved. The compounds and compositions of the invention can be used for treatment and prevention of cardiovascular disease and related disease states, particularly, hypertension or diabetes related disorders, such as, hypertensive cardiac hypertrophy, diabetic nephropathy, and the like. | 03-18-2010 |
20110281826 | STILBENE DERIVATIVES FOR ADP-RIBOSYL CYCLASE INHIBITORS - The present disclosure relates to bisphenyl compounds that are useful for inhibiting the ADP-ribosyl cyclase (ADPR-cyclase). More particularly, the disclosed compounds can be used for treatment and prevention of hypertension, hypertensive cardiac hypertrophy, diabetes, and diabetic nephropathy, in which pathogenesis ADPR-cyclase is involved. The compounds and compositions of the invention can be used for treatment and prevention of cardiovascular disease and related disease states, particularly, hypertension or diabetes related disorders, such as, hypertensive cardiac hypertrophy, diabetic nephropathy, and the like. | 11-17-2011 |
Patent application number | Description | Published |
20130170375 | WIRED/WIRELESS CONVERGED MAC ADAPTOR AND METHOD OF TRANSMITTING FRAME USING WIRED/WIRELESS CONVERGED MAC ADAPTOR - A wired/wireless converged media access control (MAC) adaptor and a method for transmitting a frame using the same. The wired/wireless converged MAC adaptor may include a service network interface (SNI) to transmit a MAC frame corresponding to a wired or wireless service, or common public radio interface (CPRI) data, a frame conversion unit to convert, into an orthogonal frequency division multiplexing (OFDM) frame, a wired/wireless converged MAC frame having a common frame structure of the MAC frame corresponding to the wired or wireless service or the CPRI data, and an OFDM interface configured to transmit the OFDM frame to an optical OFDM modem by dynamically allocating sub-carriers based on data transmission characteristics. | 07-04-2013 |
20130170830 | SIGNAL TRANSMISSION APPARATUS AND OPTICAL MODEM MODULATION METHOD - A modulation method of an optical modem and a signal transmission apparatus performing the method are disclosed. The modulation method of the optical modem includes an optical interface providing a signal to a light source, a photo detector receiving reflected light by an optical link when output light from the light source based on the provided signal is reflected by the optical link, the photo detector measuring and determining characteristics of the optical link using the reflected light, and the optical modem determining a power level and a modulation method for each subcarrier based on the characteristics of the optical link. | 07-04-2013 |
20130170834 | HYBRID PASSIVE OPTICAL NETWORK SYSTEM - Provided is a hybrid passive optical network (PON) system. The hybrid PON system of wavelength division multiplexing (WDM)/time division multiplexing (TDM) may include an optical line terminal (OLT) and an optical network unit (ONU). The OLT and the ONU may transmit a signal based on wavelength reuse using a seed light source and a reflective modulator. The light source may include a seed light source having a single wavelength, two seed light sources having different wavelength bands, and a light source having a wavelength tunable characteristic. | 07-04-2013 |
20130170836 | OPTICAL TRANSCEIVER AND WAVELENGTH INITIALIZATION METHOD USING OPTICAL TRANSCEIVER - An optical transceiver, and a wavelength initialization method using the optical transceiver are provided. The optical transceiver may include an optical transmitter to transmit an upstream signal using a first waveguide Bragg grating (WBG), an optical receiver to receive a downstream signal using a second WBG, and a control unit to control the second WBG to initialize a wavelength, so that the optical receiver receives a maximum optical power. | 07-04-2013 |
20130170837 | CONVERGED PON FOR TDMA-PON SERVICE BASED ON OFDMA-PON - A converged passive optical network (CPON) and a data transmission method are disclosed. The CPON is a combination of a time division multiple access-passive optical network (TDMA-PON) and an orthogonal frequency division multiple access-passive optical network (OFDMA-PON) and is able to dynamically controlling a bandwidth for upstream signal transmission through allocation of multiple subcarriers to each single optical network unit (ONU). | 07-04-2013 |
Patent application number | Description | Published |
20130093932 | ORGANIC PIXELS INCLUDING ORGANIC PHOTODIODE, MANUFACTURING METHODS THEREOF, AND APPARATUSES INCLUDING THE SAME - Provided is an organic pixel, which includes a semiconductor substrate including a pixel circuit, an interconnection layer having a first contact and a first electrode formed on a semiconductor substrate, and an organic photo-diode formed on the interconnection layer. For example, the organic photo-diode includes an insulation layer formed on the first electrode, a second electrode and a photo-electric conversion region formed between the first contact, the insulation layer and the second electrode. The photo-electric conversion region includes an electron donating organic material and an electron accepting organic material. The organic photo-diode may further include a second contact electrically connected to the first contact. The horizontal distance between the second contacts and the insulation layer may be less than or equal to a few micrometers, for example, 10 micrometers. | 04-18-2013 |
20150054995 | ORGANIC PIXELS INCLUDING ORGANIC PHOTODIODE, MANUFACTURING METHODS THEREOF, AND APPARATUSES INCLUDING THE SAME - Provided is an organic pixel, which includes a semiconductor substrate including a pixel circuit, an interconnection layer having a first contact and a first electrode formed on a semiconductor substrate, and an organic photo-diode formed on the interconnection layer. For example, the organic photo-diode includes an insulation layer formed on the first electrode, a second electrode and a photo-electric conversion region formed between the first contact, the insulation layer and the second electrode. The photo-electric conversion region includes an electron donating organic material and an electron accepting organic material. The organic photo-diode may further include a second contact electrically connected to the first contact. The horizontal distance between the second contacts and the insulation layer may be less than or equal to a few micrometers, for example, 10 micrometers. | 02-26-2015 |
Patent application number | Description | Published |
20140088668 | COLOR LIGHT THERAPY DEVICE - Provided is a color light therapy device. The color light therapy device includes: a body that is used by being attached to a color light therapy portion of a human body by using a double-sided adhesive tape, a hydrogel pad, or an air suction plate, and includes a printed circuit board (PCB) that supplies driving power to a light source that emits color light in a given wavelength range to perform color light therapy on the human body; and a power jack that is connected to the PCB of the body through an electric wire. Since a user may use the color light therapy device by connecting the power jack to a mobile phone, a PC, a laptop, a tablet PC, a smartphone, a personal digital assistant (PDA), a vehicle, or a socket at home while carrying the color light therapy device, anyone may conveniently use the color light therapy device to perform color light therapy on the human body without exchanging or charging a battery. | 03-27-2014 |
20140135875 | APPARATUS FOR RELAXING SMOOTH MUSCLES OF HUMAN BODY - An apparatus for relaxing smooth muscles of a human body, capable of directly radiating light having a predetermined wavelength range for inducing relaxation of the smooth muscles onto acupuncture points related to an organ consisting of smooth muscles via an electrode probe. The apparatus includes a controller body to determine whether a light radiation mode is selected and an operation is started through a direct manipulation using a switch, and output an LED driving signal to an electrode probe connection terminal; and wired and wireless electrode probes to be attached to/detached from the terminal to be electrically connected to/disconnected from the controller body, and to be driven by the driving signal to emit light having a predetermined wavelength range which increases concentration of a material for relaxing the muscles. Accordingly, the apparatus promotes blood and lymph circulation in an organ consisting of smooth muscles by relaxing those muscles. | 05-15-2014 |
Patent application number | Description | Published |
20100069619 | STILBENE DERIVATIVES FOR ADP-RIBOSYL CYCLASE INHIBITORS - The present disclosure relates to bisphenyl compounds that are useful for inhibit the ADP-ribosyl cyclase (ADPR-cyclase). More particularly, the disclosed compounds can be used for treatment and prevention of hypertension, hypertensive cardiac hypertrophy, diabetes, and diabetic nephropathy, in which pathogenesis ADPR-cyclase is involved. The compounds and compositions of the invention can be used for treatment and prevention of cardiovascular disease and related disease states, particularly, hypertension or diabetes related disorders, such as, hypertensive cardiac hypertrophy, diabetic nephropathy, and the like. | 03-18-2010 |
20110281826 | STILBENE DERIVATIVES FOR ADP-RIBOSYL CYCLASE INHIBITORS - The present disclosure relates to bisphenyl compounds that are useful for inhibiting the ADP-ribosyl cyclase (ADPR-cyclase). More particularly, the disclosed compounds can be used for treatment and prevention of hypertension, hypertensive cardiac hypertrophy, diabetes, and diabetic nephropathy, in which pathogenesis ADPR-cyclase is involved. The compounds and compositions of the invention can be used for treatment and prevention of cardiovascular disease and related disease states, particularly, hypertension or diabetes related disorders, such as, hypertensive cardiac hypertrophy, diabetic nephropathy, and the like. | 11-17-2011 |
Patent application number | Description | Published |
20100069619 | STILBENE DERIVATIVES FOR ADP-RIBOSYL CYCLASE INHIBITORS - The present disclosure relates to bisphenyl compounds that are useful for inhibit the ADP-ribosyl cyclase (ADPR-cyclase). More particularly, the disclosed compounds can be used for treatment and prevention of hypertension, hypertensive cardiac hypertrophy, diabetes, and diabetic nephropathy, in which pathogenesis ADPR-cyclase is involved. The compounds and compositions of the invention can be used for treatment and prevention of cardiovascular disease and related disease states, particularly, hypertension or diabetes related disorders, such as, hypertensive cardiac hypertrophy, diabetic nephropathy, and the like. | 03-18-2010 |
20110281826 | STILBENE DERIVATIVES FOR ADP-RIBOSYL CYCLASE INHIBITORS - The present disclosure relates to bisphenyl compounds that are useful for inhibiting the ADP-ribosyl cyclase (ADPR-cyclase). More particularly, the disclosed compounds can be used for treatment and prevention of hypertension, hypertensive cardiac hypertrophy, diabetes, and diabetic nephropathy, in which pathogenesis ADPR-cyclase is involved. The compounds and compositions of the invention can be used for treatment and prevention of cardiovascular disease and related disease states, particularly, hypertension or diabetes related disorders, such as, hypertensive cardiac hypertrophy, diabetic nephropathy, and the like. | 11-17-2011 |